J. Balogh et al. / Journal of Organometallic Chemistry 718 (2012) 131e138
137
4.3. General procedure for the synthesis of ethyl 4-oxo-2,6-
4.3.4. Ethyl 2,6-diferrocenyl-1,3-di(prop-2-ynyl)-tetrahydro-4(1H)-
diferrocenyl-hexahydropyrimidine-5-carboxylate derivatives 8aee
pyrimidinone-5-carboxylate, racemic mixture of (2R,5S,6R) and
(2S,5R,6S) isomers (8d)
In a typical reaction ferrocenylimine (4aee) (0.300 mmol), ethyl
1H NMR (400 MHz, CDCl3):
d
¼ 5.94 (s, 1H), 5.31 (d, J ¼ 15.6 Hz,
diazoacetate (1) (32
ml, 0.300 mmol), Co2(CO)8 (5.1 mg, 0.015 mmol)
1H), 4.60 (d, J ¼ 11.5 Hz, 1H), 4.47 (m, 1H), 4.29 (m, 1H), 4.25 (s,
5H), 4.17e4.22 (m, 6H), 4.06e4.16 (m, 3H), 3.92 (s, 5H), 3.48 (d,
J ¼ 11.5 Hz, 1H), 3.33 (d, J ¼ 16.0 Hz, 1H), 3.07 (d, J ¼ 15.6 Hz, 1H),
2.35 (s, 1H), 2.24 (s, 1H), 1.31 (t, J ¼ 7.1 Hz, 3H). 13C NMR
and CH2Cl2 (2 mL) were transferred under an inert atmosphere into
a 30 mL stainless steel autoclave. It was charged with carbon
monoxide (40 bar at room temperature) and stirred at room
temperature for 24 h. The evaporation of the solvent and column
chromatography (silica, hexane/EtOAc ¼ 3/1) led to the products.
Crystals suitable for X-ray analysis were grown by recrystallisation
from n-hexane/EtOAc ¼ 3/1.
(100.62 MHz, CDCl3):
d
¼ 169.4, 164.1, 86.3, 85.4, 80.8, 78.3, 73.3,
73.0, 72.2, 69.2, 69.1, 69.0; 68.7, 68.2, 68.0, 67.4, 67.1, 66.7, 66.4,
61.6, 53.1, 50.3, 34.8, 34.1, 14.1. IR (KBr, cmꢀ1): 1741; 1650. MS: m/z
1255 ((2M þ Na)þ)/35, 639 ((M þ Na)þ)/100, 617 ((M þ H)þ)/70,
616 (Mþ)/52, 311/50. Anal. Calcd. for C33H32Fe2N2O3 (616.32): C
64.31, H 5.23, N 4.55; found C 64.53, H 5.01, N 4.44. Orange
chunks, Rf ¼ 0.31 (hexane/EtOAc, 3:1); m.p. 186e190 ꢁC. Yield
53%.
4.3.1. Ethyl 1,3-dibenzyl-2,6-diferrocenyl-tetrahydro-4(1H)-
pyrimidinone-5-carboxylate, racemic mixture of (2R,5S,6R) and
(2S,5R,6S) isomers (8a)
1H NMR (400 MHz, CDCl3):
d
¼ 7.27e7.30 (m, 5H), 7.03e7.11 (m,
3H), 6.57 (dd, J ¼ 6.5, 1.5 Hz, 2H), 5.67 (d, J ¼ 14.3 Hz, 1H); 5.00 (s,
1H); 4.83 (d, J ¼ 11.8 Hz, 1H); 4.37e4.38 (m, 1H); 4.35e4.37 (m, 1H);
4.29e4.30 (m,1H); 4.26 (d, J ¼ 7.1 Hz, 2H); 4.17e4.22 (m, 3H); 4.08e
4.09 (m, 1H); 4.03e4.00 (m, 2H); 3.97 (s, 5H); 3.86 (s, 5H); 3.51 (d,
J ¼ 11.8 Hz, 1H); 3.40 (d, J ¼ 13.4 Hz, 1H); 2.68 (d, J ¼ 13.4 Hz, 1H);
4.3.5. Ethyl 1,3-bis(cyclohexylmethyl)-2,6-diferrocenyl-tetrahydro-
4(1H)-pyrimidinone-5-carboxylate, racemic mixture of (2R,5S,6R)
and (2S,5R,6S) isomers (8e)
1H NMR (400 MHz, CDCl3):
d
¼ 5.36 (s, 1H), 4.57 (d, J ¼ 11.9 Hz,
1H); 4.38e4.41 (m, 1H), 4.16e4.23 (m, 8H), 4.10 (s, 5H), 4.00e4.02
(m,1H), 3.96e3.98 (m,1H), 3.78 (s, 5H), 3.37 (d, J ¼ 11.9 Hz,1H), 3.12
(dd, J ¼ 13.6, 5.6 Hz,1H), 2.12 (dd, J ¼ 12.9, 3.6 Hz,1H),1.89e1.99 (m,
1H), 0.95e1.74 (m, 20 H), 1.28 (t, J ¼ 7.1 Hz, 3H), 0.65e0.77 (m, 1H),
1.33 (t, J ¼ 7.1 Hz, 3H). 13C NMR (100.62 MHz, CDCl3):
d
¼ 169.9,
164.9, 138.2, 137.5, 129.1, 128.8, 128.4, 128.0, 127.9, 126.9, 87.6, 86.3,
72.3, 69.1, 69.0, 68.7, 68.6, 68.5, 67.8, 67.4, 67.1, 66.7, 66.6, 61.5, 53.5,
50.1, 48.3, 47.4, 14.1. IR (KBr, cmꢀ1): 1740; 1638. MS: m/z 720 (Mþ)/
84, 418/100, 285/32, 177/21, 137/32. Anal. Calcd. for C41H40Fe2N2O3
(720.47): C 68.35, H 5.60, N 3.89; found C 68.51, H 5.70, N 3.72.
Amber blocks, Rf ¼ 0.36 (hexane/EtOAc, 3:1); m.p. 205e209 ꢁC.
Yield 52%.
0.54e0.65 (m, 1H). 13C NMR (100.62 MHz, CDCl3):
d
¼ 168.6, 163.8,
86.7, 84.9, 72.2, 67.6, 67.5, 67.4, 67.1, 67.0, 66.4, 65.6, 65.3, 65.1, 64.7,
59.7, 51.9, 49.4, 48.1 (2C), 35.5, 34.6, 30.0, 29.8, 29.7, 29.6, 25.2, 24.9,
24.7, 24.5, 24.4, 24.3, 12.6 IR (KBr, cmꢀ1): 1733; 1650. MS: m/z 733
((M þ H)þ)/4, 547/14, 518/4, 451/4, 430/14, 386/21, 311/100, 285/14,
239/25, 219/14, 186/14, 137/7. Anal. Calcd. for C41H52Fe2N2O3
(732.57): C 67.22, H 7.15, N 3.82; found C 66.89, H 7.37, N 3.96.
Yellow solid, Rf ¼ 0.48 (hexane/EtOAc, 3:1); m.p. 175e179 ꢁC.
Yield 53%.
4.3.2. Ethyl 2,6-diferrocenyl-1,3-bis(4-methoxybenzyl)-tetrahydro-
4(1H)-pyrimidinone-5-carboxylate, racemic mixture of (2R,5S,6R)
and (2S,5R,6S) isomers (8b)
1H NMR (400 MHz, CDCl3):
d
¼ 7.22 (d, J ¼ 8.7 Hz, 2H), 6.81 (d,
J ¼ 8.7 Hz, 2H), 6.61 (d, J ¼ 8.7 Hz, 2H), 6.51 (d, J ¼ 8.7 Hz, 2H), 5.60
(d, J ¼ 14.2 Hz, 1H), 5.00 (s, 1H), 4.80 (d, J ¼ 11.8 Hz, 1H), 4.34e4.38
(m, 2H), 4.16e4.31 (m, 6H), 4.04e4.07 (m, 1H), 3.98e4.01 (m, 1H),
4.00 (s, 5H), 3.92 (d, J ¼ 14.2 Hz, 1H), 3.86 (s, 5H), 3.79 (s, 3H), 3.71
(s, 3H), 3.48 (d, J ¼ 11.8 Hz, 1H), 3.32 (d, J ¼ 13.1 Hz, 1H), 2.60 (d,
J ¼ 13.1 Hz, 1H), 1.33 (t, J ¼ 7.1 Hz, 3H). 13C NMR (100.62 MHz,
4.4. General procedure for the synthesis of ethyl 4-oxo-2,6-
diferrocenyl-hexahydropyrimidine-5-carboxylate derivatives 9aec
and 10e
In a typical reaction ferrocenylimine (4aee) (0.300 mmol), ethyl
diazoacetate (1) (40 ml, 0.375 mmol), Co2(CO)8 (5.1 mg, 0.015 mmol)
CDCl3):
d
¼ 170.2, 165.1, 159.6, 158.8; 130.7, 130.5, 129.9, 129.7, 114.4,
and CH2Cl2 (2 mL) were transferred under an inert atmosphere into
a 30 mL stainless steel autoclave. It was charged with carbon
monoxide (80 bar at room temperature) and stirred at room
temperature for 8 h. Then the pressure was decreased to 40 bar and
the reaction mixture was stirred at room temperature for 16 h. The
evaporation of the solvent and column chromatography
(silica, hexane/EtOAc ¼ 3/1) led to the products. Crystals suitable
for X-ray analysis were grown by recrystallisation from n-hexane/
EtOAc ¼ 3/1.
113.6, 88.0, 86.7, 72.1, 69.4, 69.2, 68.9. 68.8. 68.7, 68.0, 67.6, 67.3,
67.0, 66.8, 61.7, 55.6, 55.5, 53.7, 50.3, 47.9, 46.9, 14.3. IR (KBr, cmꢀ1):
1736; 1643. MS: m/z 780 (Mþ)/21, 595/14, 448/36, 334/95, 285/100.
Anal. Calcd. for C43H44Fe2N2O5 (780.52): C 66.17, H 5.68, N 3.59;
found C 65.85, H 5.81, N 3.42. Yellow solid, Rf ¼ 0.21 (hexane/EtOAc,
3:1); m.p. 186e191 ꢁC. Yield 62%.
4.3.3. Ethyl 1,3-dibutyl-2,6-diferrocenyl-tetrahydro-4(1H)-
pyrimidinone-5-carboxylate, racemic mixture of (2R,5S,6R) and
(2S,5R,6S) isomers (8c)
4.4.1. Ethyl 1,3-dibenzyl-2,6-diferrocenyl-tetrahydro-4(1H)-
pyrimidinone-5-carboxylate, racemic mixture of (2S,5S,6R) and
(2R,5R,6S) isomers (9a)
1H NMR (400 MHz, CDCl3):
d
¼ 5.28 (s, 1H), 4.58 (d, J ¼ 11.8 Hz,
1H), 4.37e4.40 (m,1H), 4.22e4.25 (m, 2H), 4.20e4.22 (m, 2H), 4.19e
4.20 (m,1H), 4.16e4.19 (m, 3H), 4.10 (s, 5H), 3.99e4.01 (m,1H), 3.95e
3.97 (m,1H), 3.78 (s, 5H), 3.33 (d, J ¼ 11.8 Hz,1H), 3.16e3.25 (m,1H),
2.18e2.25 (m, 1H), 2.05e2.12 (m, 1H), 1.10e1.68 (m, 8H), 1.28 (t,
J ¼ 7.1 Hz, 3H), 0.92 (t, J ¼ 7.3 Hz, 3H); 0.79 (t, J ¼ 7.1 Hz, 3H).13C NMR
1H NMR (400 MHz, CDCl3):
d
¼ 7.39e7.50 (m, 5H), 7.25e7.32
(m, 3H), 6.86e6.92 (m, 2H), 5.70 (d, J ¼ 14.7 Hz, 1H), 5.27 (s, 1H),
3.83e4.47 (m, 12H), 3.95 (s, 5H), 3.85 (d, J ¼ 12.8 Hz, 1H), 3.78 (s,
5H), 3.46 (d, J ¼ 10.0 Hz, 1H), 3.31 (d, J ¼ 12.8 Hz, 1H), 1.38 (t,
(100.62 MHz, CDCl3):
d
¼ 170.1,164.7, 88.0, 86.6, 73.2, 70.1, 69.9, 69.0,
J ¼ 7.2 Hz, 3H). 13C NMR (100.62 MHz, CDCl3):
¼ 170.0, 167.1, 138.6,
d
68.7, 68.1, 68.0, 67.0, 66.8, 66.5, 66.3, 61.3, 53.6, 49.8, 45.0, 42.8, 30.6,
29.4, 20.3, 20.0, 14.1, 14.0, 13.9. IR (KBr, cmꢀ1): 1738; 1642. MS: m/z
653 ((M þ H)þ)/36, 476/32, 384/36, 346/58, 285/100, 219/37,186/23,
150/10, 39/5. Anal. Calcd. for C35H44Fe2N2O3 (652.44): C 64.43, H
6.80, N 4.29; found C 64.64, H 6.97, N 4.13. Orange solid, Rf ¼ 0.37
(hexane/EtOAc, 3:1); m.p. 174e178 ꢁC. Yield 41%.
137.2, 129.5, 129.1, 128.9, 128.2, 128.1, 127.5, 91.1, 87.4, 72.3, 69.7,
68.8, 68.7, 68.1, 67.8, 67.5, 67.0, 66.6, 66.5, 66.3, 61.5, 60.0, 59.4, 53.5,
48.9, 14.2. MS: m/z 720 (Mþ)/26, 681/16, 535/26, 418/68, 304/100,
239/21, 151/68. Anal. Calcd. for C41H40Fe2N2O3 (720.47): C 68.35, H
5.60, N 3.89; found C 68.12, H 5.41, N 4.03. Yellow blocks, Rf ¼ 0.45
(hexane/EtOAc, 3:1); m.p. 208e212 ꢁC. Yield 24%.